Winslow Capital Management
TMO icon

Winslow Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Winslow Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-904
Closed -$525K – 61
2024
Q1 		$525K Sell
904
-627,943
-100% -$352M ﹤0.01% 51
2023
Q4 		$334M Buy
+628,847
New +$304M 1.38% 27
2021
Q1 		– Sell
-631
Closed -$294K – 69
2020
Q4 		$294K Sell
631
-675,336
-100% -$317M ﹤0.01% 60
2020
Q3 		$298M Sell
675,967
-25,699
-4% -$10.6M 1.33% 24
2020
Q2 		$254M Sell
701,666
-126,521
-15% -$42.4M 1.24% 25
2020
Q1 		$235M Sell
828,187
-62,333
-7% -$19.7M 1.44% 27
2019
Q4 		$289M Sell
890,520
-33,486
-4% -$10.2M 1.5% 27
2019
Q3 		$269M Sell
924,006
-19,412
-2% -$5.56M 1.47% 24
2019
Q2 		$277M Sell
943,418
-247,214
-21% -$68.1M 1.48% 29
2019
Q1 		$326M Sell
1,190,632
-171,317
-13% -$42.6M 1.77% 20
2018
Q4 		$305M Sell
1,361,949
-122,546
-8% -$28.8M 1.89% 17
2018
Q3 		$362M Sell
1,484,495
-34,523
-2% -$7.94M 1.8% 18
2018
Q2 		$315M Sell
1,519,018
-163,530
-10% -$34.7M 1.65% 21
2018
Q1 		$347M Sell
1,682,548
-74,061
-4% -$15.5M 1.88% 13
2017
Q4 		$334M Sell
1,756,609
-374,443
-18% -$71.7M 1.83% 17
2017
Q3 		$403M Buy
2,131,052
+291,345
+16% +$52.8M 2.17% 13
2017
Q2 		$321M Sell
1,839,707
-358,467
-16% -$60.2M 1.71% 19
2017
Q1 		$338M Buy
2,198,174
+439,847
+25% +$67.2M 1.61% 23
2016
Q4 		$248M Sell
1,758,327
-124,324
-7% -$18.3M 1.14% 39
2016
Q3 		$299M Buy
+1,882,651
New +$290M 1.25% 30

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Winslow Capital Management's TMO Position: Q2 2024 in Review

Winslow Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 904 shares — an estimated $525K sold.

Winslow Capital Management first reported a position in TMO in Q3 2016 and held it in 20 quarters. The position peaked at $403M in Q3 2017. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Winslow Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Winslow Capital Management sold 904 Thermo Fisher Scientific shares in Q2 2024, an estimated $525K.
  • Winslow Capital Management first reported a position in Thermo Fisher Scientific in Q3 2016 and held it in 20 quarters.
  • Winslow Capital Management's Thermo Fisher Scientific position peaked at $403M in Q3 2017.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Winslow Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.